Biotech ICL
What is Biotech ICL?
Biotech ICL, short for “Implantable Collamer Lens,” is a cutting-edge vision correction technology used to treat various refractive vision problems, such as myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. Unlike traditional eyeglasses or contact lenses, Biotech ICL is a surgically implanted, biocompatible lens that is placed inside the eye, specifically in front of the eye’s natural lens but behind the iris. This positioning allows the ICL to work in harmony with the eye’s natural focusing system to correct vision.
The key advantage of Biotech ICL is its ability to provide clear and stable vision without the need for removing corneal tissue, making it an attractive option for individuals with thin corneas or those who are not suitable candidates for laser eye surgery. This procedure is typically quick and minimally invasive, offering rapid visual recovery and a high degree of predictability in terms of visual outcomes. Biotech ICL has gained popularity for its effectiveness in achieving vision correction with enhanced comfort and quality of life for many patients.
Book Free Consultation
Book Appointment or Video Consultation online with top eye doctors
Types of Biotech ICL
Biotech ICL (Implantable Collamer Lens) is a brand of implantable lenses used for vision correction. There are several types and variations of Biotech ICL lenses designed to address different vision issues and patient needs. Some of the common types include:
- Toric ICL: Toric ICLs are designed to correct astigmatism in addition to myopia or hyperopia. They have a special toric design that can rotate within the eye to align with the astigmatism axis for precise correction.
- V4c ICL: The V4c (Visian for correction) ICL is a standard version used to correct myopia and hyperopia. It’s a versatile option for a wide range of refractive errors.
- EVO Visian ICL: The EVO Visian ICL is an advanced version with a central hole (a “hole ICL”), designed to improve the flow of natural eye fluids. This can reduce the risk of complications like elevated intraocular pressure.
- Collamer® CentraFLOW Technology: This technology is incorporated into some Biotech ICLs, including the EVO Visian ICL, to maintain the natural balance of eye fluid and reduce the risk of cataracts or glaucoma.
- Visian ICL for Keratoconus: Some Biotech ICLs are specifically tailored for patients with keratoconus, a progressive eye condition. These lenses are designed to provide visual improvement for individuals with both keratoconus and myopia or hyperopia.
About the Manufacturer
The manufacturer of Biotech ICL lenses is STAAR Surgical Company, a global leader in the development and manufacturing of implantable eye devices. STAAR Surgical, founded in 1982 and headquartered in California, specializes in innovative ophthalmic solutions, including the Visian ICL product line.
Their advanced technology and commitment to research and development have made them a trusted provider of implantable collamer lenses, helping millions of people worldwide achieve improved vision and a better quality of life through vision correction procedures.
Advantages of Biotech ICL
Biotech ICL (Implantable Collamer Lens) is a medical device used in ophthalmology to correct vision problems, particularly high myopia (nearsightedness). There are several advantages associated with Biotech ICL lenses:
- High Precision: Biotech ICL is known for its precise correction of vision problems. It is custom-made for each patient’s eye, taking into account their specific prescription and eye measurements. This individualized approach ensures accurate vision correction.
- Excellent Visual Quality: Patients often report excellent visual quality with Biotech ICL lenses. The lenses do not induce dry eye symptoms or cause night vision issues that can sometimes be associated with other vision correction methods.
- UV Protection: Biotech ICL lenses are made of a material that offers UV protection, helping to protect the eye from harmful ultraviolet rays from the sun.
ICL Eye Surgery Cost
The cost of ICL (Implantable Collamer Lens) surgery typically ranges from ₹50,000 to ₹80,000 per eye. Prices may vary based on the specific location, the surgeon’s experience, and the type of ICL used. Overall, ICL surgery is often more affordable in India compared to many other countries.
| Procedure | Price/Eye (₹) | Lens / Procedure Type |
|---|---|---|
| LASIK | 30,000 | C-Lasik / PRK |
| Basic ICL Surgery | 35,000 | Indian Lens |
| IPCL / Biotech Lens Surgery | 50,000 | Toric Lens |
| IPCL / Biotech Lens Surgery | 60,000 | Non-Toric Lens |
| EVO Staar Visian ICL Lens Surgery | 65,000 | Toric Lens |
| EVO Staar Visian ICL Lens Surgery | 75,000 | Non-Toric Lens |
Best Hospital
India is home to several renowned eye hospitals, including institutions like the L.V. Prasad Eye Institute, Sankara Nethralaya, AIIMS, and Eye Mantra, all of which offer ICL surgery services. Eye Mantra, in particular, is well-equipped with state-of-the-art technology and advanced equipment to provide a comprehensive range of eye care services. This includes procedures such as LASIK, SMILE, Contura, and ICL, all of which are offered at affordable rates. Our primary objective is to enhance the vision and overall quality of life for our valued patients.
If you are contemplating Biotech ICL eye surgery, we strongly encourage you to arrange an appointment with our team of experts. This initial consultation will enable our specialists to evaluate your unique eye condition and recommend the most suitable treatment tailored to your specific needs. We are fully dedicated to assisting you in achieving clearer vision and better overall eye health.
Frequently Asked Questions
Biotech ICL (Implantable Collamer Lens) can effectively treat a wide range of refractive errors, including myopia (nearsightedness) and hyperopia (farsightedness). The power range typically extends from about -3.0 to -20.0 diopters for myopia and up to +10.0 diopters for hyperopia, making it suitable for individuals with moderate to high refractive errors.
The delivery time for Biotech ICL (Implantable Collamer Lens) can vary depending on several factors, including the specific lens customization, the surgeon’s schedule, and the patient’s availability for surgery. Generally, the process, from initial consultation to surgery and lens implantation, can take a few weeks to a couple of months to ensure proper customization and preparation.
Biotech ICL (Implantable Collamer Lens) offers advantages over other vision correction methods like LASIK and traditional contact lenses. It provides a reversible, stable, and precise vision correction, suitable for a wide range of refractive errors.
Biotech ICL (Implantable Collamer Lens) is generally considered safe when performed by experienced eye surgeons and when appropriate precautions are taken. However, like any surgical procedure, there are potential risks and complications associated with ICL implantation. Some potential risks include infection, cataracts, increased intraocular pressure, glare, and halos around lights, although these are relatively rare.
Whether or not Biotech ICL (Implantable Collamer Lens) is covered by insurance depends on several factors, including the specific insurance plan, the reason for the procedure, and the patient’s individual circumstances.
